EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
US8183286B2 · kind B2 · utility
3Cited by
12References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 2007 |
| Grant date | May 22, 2012 |
| Priority date | — |
| Expiry date | Feb 4, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/343
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to the use of EP2 and/or EP4 agonists as therapeutics for the treatment of diseases associated with influenza A viruses, such as for example H5N1 and mutations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.